Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactos 2018-10-02
ATAI Life Science–SEVERAL: investment, 201810 1st financing round €21.2m from private investors 2018-10-01
B Braun–CeGaT: personalised medicine, 201810 collab establishment JV to develop personalised cancer vaccines CeCaVa GmbH & Co KG 2018-10-01
Forbion–SEVERAL: investment, 201810 final close €360m of Forbion IV fund 2018-10-01
Helmholtz–Bruker Corp: MRI system, 201810 supply 9.4 Tesla preclinical MRI system with integrated PET detector to DKFZ 2018-10-01
Novaliq–Hopp Group: investment, 201810 financing round €44.9m from Dievini Hopp BioTech Holding GmbH 2018-10-01
Strüngmann Group–Cyclenium: anti-infectives, 201810– collab discovery using CMRT technology + QUEST Library with AiCuris 2018-10-01
Pfizer–Qiagen: companion diagnostics, 201809 collab existent CDx for precision medicines in onocology 2018-09-28
Tusk Therapeutics–Roche: investment, 201809 acquisition for €70m cash + €585m milestones with some assets spun out into Black Belt Therapeutics 2018-09-28
Bayer–Genedata: bioinformatics, 201809– license to Genedata Selector s/w for Bayer CropScience division for develop new fungicides 2018-09-27
Genewiz–Brooks Automation: investment, 201809– acquisition $450m of Genewiz by Brooks ANNOUNCED 2018-09-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Valneva–SEVERAL: investment, 201809 private placement €50m with 13.33m new ordinary shares at €3.75/share led by US healthcare investors 2018-09-26
Aktiia–Redalpine: investment, 201809 seed financing round totalling CHF4m led by TransLink Capital + Redalpine 2018-09-25
Aktiia–SEVERAL: investment, 201809 seed financing round CHF4m led by TransLink Capital + Redalpine 2018-09-25
Aktiia–TransLink Capital: investment, 201809 seed financing round totalling CHF4m led by TransLink Capital + Redalpine 2018-09-25
Sachem–Thermo FIsher: mass spectrometer, 201809 supply existent ISQ EM single quad system early customer 2018-09-24
Tolremo Therapeutics–Altos Venture: investment, 201809 financing round Series A totalling CHF9m incl new + co-investor Altos Venture 2018-09-24
Tolremo Therapeutics–BioMedPartners: investment, 201809 financing round Series A totalling CHF9m incl new + lead investor BioMedPartners 2018-09-24
Tolremo Therapeutics–Redalpine: investment, 201809 financing round Series A totalling CHF9m incl new + co-investor Redalpine 2018-09-24
Tolremo Therapeutics–SEVERAL: investment, 201809 financing round Series A CHF9m led by BioMedPartners 2018-09-24
Tolremo Therapeutics–Zürcher Kantonalbank: investment, 201809 financing round Series A totalling CHF9m incl exisintg + co-investor ZKB 2018-09-24
India (govt)–Thermo Fisher: mass spectrometry, 201809 collab food testing solutions using MS + chromatography with FSSAI 2018-09-20
Plug and Play–Roche: healthcare, 201809–202108 collab creation of Startup Creasphere innovation program in Munich with Roche Diagnostics 2018-09-20
Univ Salzburg–Thermo Fisher: mass spectrometry, 201809 collab biopharma characterisation with LC-MS with CDL at Univ Salzburg 2018-09-20
CRISPR Therapeutics–SEVERAL: investment, 201809 public offering $200m net $185.7m with 4.21m common shares at $46.5/share 2018-09-19
BluCon Biotech–BRAIN: industrial biotechnology, 201809– strategic research collab microbial strain developm for PLA-based bioplastic 2018-09-18
GeNeuro–Servier: investment, 201809 existent investor Servier 2018-09-18
Almirall–Evotec: drug discovery services, 201809– collab r+d therapies for dermatological diseases 2018-09-17
Iowa State Univ–Thermo Fisher: mass spectrometry, 201809 supply existent early user of new VetDrugs Explorer Collection LC-MS/MS solution 2018-09-17
Luciole Medical–SEVERAL: investment, 201809 financing round Series A CHF5.3m (€4.7m) led by SVC Ltd (CreditSuisse) 2018-09-17
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification 2018-09-10
RSP Systems–SEVERAL: investment, 201809 financing round Series B 2nd closing €3.85m incl new investor Trumpf Venture GmbH 2018-09-10
RSP Systems–Trumpf: investment, 201809 financing round Series B 2nd closing totalling €3.85m incl new investor Trumpf Venture GmbH 2018-09-10
Menarini–Lunaphore: staining technology, 201809– collab Menarini Diagnostics to market LabSat Frozen tissue staining solution 2018-09-09
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Novartis–Aurobindo: investment, 201809 acquisition $900m cash + $100m milestones of Sandoz US dermatology + oral generics businesses by Aurobindo USA 2018-09-06
Polyphor–Novo Group: investment, 201809 capital increase CHF6.8m with 179k shares at CHF38/share sold to Novo REPAIR Impact Fund 2018-09-06
Polyphor–Novo Group: investment, 201809– project-based + royalty-bearing investment up to CHF4.7m based on milestones in OMPTA program by Novo REPAIR 2018-09-06
Twentyeight-Seven–Astellas: investment, 201809 financing round Series A totalling $65m incl co-investor Astellas Venture Management 2018-09-06
Twentyeight-Seven–JnJ: investment, 201809 financing round Series A totalling $65m incl co-investor JnJ Innovation JJDC Inc 2018-09-06
Twentyeight-Seven–Longwood Fund: investment, 201809 financing round Series A totalling $65m incl co-investor Longwood Fund 2018-09-06
Twentyeight-Seven–MPM Capital: investment, 201809 financing round Series A totalling $65m incl founding + co-lead investor MPM Capital 2018-09-06
Twentyeight-Seven–Novartis: investment, 201809 financing round Series A totalling $65m incl co-lead investor NVF 2018-09-06
Twentyeight-Seven–SEVERAL: investment, 201809 financing round Series A $65m co-led by founding investor MPM Capital + NVF 2018-09-06
Twentyeight-Seven–Temasek: investment, 201809 financing round Series A totalling $65m incl co-investor Vertex Ventures HC 2018-09-06
Miracor–SEVERAL: investment, 201809 financing round Series D totalling €30m final closing led by Ming Capital (CN) 2018-09-04
Mologen–SEVERAL: investment, 201809 capital increase €8.2m with 1.73m new shares at €4.7/share to existing + new investors 2018-09-03
CHDI–Evotec: drug discovery services, 201808–2023 collab service extension CDHI funding up to 75 full-time scientists for Huntington’s disease drugs 2018-08-30
Lunaphore–SEVERAL: investment, 201808 financing round Series B CHF5.3m from existing + new investors 2018-08-30
Nebula Genomics–Heartbeat Labs: investment, 201808 seed financing round totalling $4.3m incl Heartbeat Labs 2018-08-29
Nebula Genomics–SEVERAL: investment, 201808 seed financing round $4.3m from ten leading tech + biotech VCs 2018-08-29
PhagoMed–Austria (govt): grant, 201808–2021 research project grant €3.5m from FFG 2018-08-28
PhagoMed–Austria (govt): investment, 201808 seed financing round totalling €1.55m incl €800k aws-Seedfinancing 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round totalling €1.55m incl €750k from private investors 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round €1.55m from private investors + aws 2018-08-28
Evotec–Centogene: drug discovery, 201808– collab ww strategic €na discovery + developm of treatments for rare genetic diseases 2018-08-27
Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech 2018-08-27
Thermo Fisher–BioStrata: public relations, 201808 service existent by BioStrata 2018-08-27
Univ Wisconsin–Thermo Fisher: FAIMS technology, 201808 supply use of FAIMS device for shotgun proteomics by Joshua Coon 2018-08-27
Hain Lifescience–Bruker Corp: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED 2018-08-24
c-LEcta–Capricorn Venture Partners: investment, 201808 financing round incl new + lead investor Capricorn investing via CSCF NV + Quest for Growth 2018-08-23
c-LEcta–SEVERAL: investment, 201808 financing round €na with new investors Capricorn Venture Partners + bm|t 2018-08-23
c-LEcta–Thuringia (govt): investment, 201808 financing round incl new + co-investor bm|t via MFT Mittelstands-Fonds Thüringen 2018-08-23
Novaremed–SEVERAL: investment, 201804 financing round CHF4.44m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Novaremed–SEVERAL: investment, 201808 financing round CHF6m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam 2018-08-22
Novo Group–Evotec: drug discovery services, 201808– collab €na strategic alliance r+d small molecule drugs for diabetes + obesity Novo Nordisk 2018-08-22
SolasCure–BRAIN: investment, 201808 financing round Series A with participation of BRAIN at spin-off of SolasCure from BRAIN 2018-08-22
SolasCure–BRAIN: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure 2018-08-22
SolasCure–SEVERAL: investment, 201808 financing round Series A with participation of BRAIN 2018-08-22
NuGen–Tecan: investment, 201808 acquisition $54.5m in cash by Tecan 2018-08-16
Oncologie–Mologen: lefitolimod, 201808–201811 term sheet for acquisition of ww rights to lefitolimod by Oncologie TERMINATED 11/18 2018-08-15
Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD 2018-08-14
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
Akouos–Novartis: investment, 201808 financing round Series A totalling $50m incl new co-investor Novartis Venture Fund 2018-08-07
Akouos–SEVERAL: investment, 201808 financing round Series A $50m co-led by existing investors 5AM Ventures + NEA 2018-08-07
United Kingdom (govt)–Bruker Corp: NMR technology, 201808 supply £20m NMR technology to 8 UK universities funded by EPSRC + BBSRC + MRC +NERC 2018-08-06
Univ Birmingham–Bruker Corp: NMR spectrometer, 201808 supply 1GHz NMR spectrometer 2018-08-06
Univ Warwick–Bruker Corp: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer 2018-08-06
Arsanis–Gates Foundation: grant, 201808 grant $1.1.m for preclinical development of ASN500 programme 2018-08-01
Miraca–Qiagen: molecular companion diagnostics, 201808– collab with SRL to introduce of CDx tests in Japan in line with respective drug approvals 2018-08-01
B&W Tek–Metrohm: investment, 201807 acquisition €na of B&W Tek LLC + several overseas subisidiaries 2018-07-27
Biocrates–MC Services: public relations, 201807 service existent by MC Services 2018-07-25
Nabriva–SEVERAL: investment, 201807 public offering $50m net $46.1m with 18.2m ordinary shares at $2.75/share 2018-07-25
Innovative Medicines Initiative–Agena Bioscience: MassARRAY Technology, 201807– collab use of MassArray system in CANCER-ID Consortium 2018-07-24
Zavante Therapeutics–Nabriva: investment, 201807 acquisition upfront 8.2m Nabriva ordinary shares (=19.9% shareholding) + $97.5m milestones 2018-07-24
SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m 2018-07-20
Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding 2018-07-19
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
Agilent–AMETEK: FTIR analyzer, 201807 collab developm + manufacturing Miniscan IR LOG FTIR analyzer for in-field oil/grease analysis 2018-07-18
next pagenext page 1 2 3 4 5 6 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top